Over-expression of MTOR has also been suggested to be a poor prognostic factor in several human cancers, including RCC [22], lung cancer [23], breast cancer [24], laryngeal squamous cell carcinoma [25] and biliary tract adenocarcinoma [26]. This evidence concerns the gene MTOR and breast cancer.